Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesGlucose dysmetabolism and prognosis in critical illness
Internal and Emergency Medicine, 11/25/08
Lazzeri C et al. - Hyperglycemia should be regarded as a part of the systemic and complex metabolic derangements observed in critical illness in response to stress and inflammation, which can lead, independent of initial disease, to multiorgan dysfunction and death. A tight glycemic control should be constantly pursued and achieved by insulin infusion bearing in mind that the therapeutic target is fighting the systemic inflammatory response and not merely the glucose plasma levels.
Related Articles
Practice variability in the assessment and treatment of critical illness-related corticosteroid insufficiency
Journal of Critical Care, 10/02/09
Relevance Score: 70%
Poor functional recovery after a critical illness: A longitudinal study
Journal of Rehabilitation Medicine, 11/13/09
Relevance Score: 67%
Understanding, recognizing, and managing chronic critical illness syndrome
Journal of the American Academy of Nurse Practitioners, 11/05/09
Relevance Score: 67%
Severe hypocholesterolemia in surgical patients, sepsis, and critical illness
Journal of Critical Care, 10/16/09
Relevance Score: 67%
Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients
New England Journal of Medicine, 10/22/09
Relevance Score: 66%
Today in Endocrine/Metabolic...keeping you current
Receive free subspecialty "5-minute updates" via email
Hypercalcemia in Cancer Patients: Pathobiology and Management
Hormone and Metabolic Research, 12/08/09
Myxedema Coma Associated with Combination Aripiprazole and Sertraline Therapy
Annals of Pharmacotherapy, 12/03/09
Biphasic insulin aspart in the treatment of type 2 diabetes mellitus
Expert Opinion in Pharmacotherapy, 12/01/09
Sponsor
Article Search
Sponsor